# Prognostic Impact of Sleep Apnea on Cardiovascular Morbidity and Mortality, in End Stage Renal Disease Patients

> **NCT02073305** · — · UNKNOWN · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 200 (estimated)

## Conditions studied

- Obstructive Sleep Apnea
- End Stage Renal Disease

## Interventions

- **OTHER:** No Sleep Apnea
- **OTHER:** Sleep Apnea - untreated
- **DEVICE:** Sleep Apnea - treated

## Key facts

- **NCT ID:** NCT02073305
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2021-11
- **Final completion:** 2022-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02073305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02073305, "Prognostic Impact of Sleep Apnea on Cardiovascular Morbidity and Mortality, in End Stage Renal Disease Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02073305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*